Abdiel Capital Advisors LP Lowers Stock Holdings in HCA Healthcare, Inc. $HCA

Abdiel Capital Advisors LP reduced its stake in HCA Healthcare, Inc. (NYSE:HCA) by 80.6% during the 4th quarter, HoldingsChannel reports. The firm owned 67,238 shares of the company’s stock after selling 279,084 shares during the quarter. HCA Healthcare makes up approximately 44.2% of Abdiel Capital Advisors LP’s holdings, making the stock its biggest holding. Abdiel Capital Advisors LP’s holdings in HCA Healthcare were worth $31,391,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of the stock. Nordea Investment Management AB boosted its holdings in shares of HCA Healthcare by 11.2% in the 4th quarter. Nordea Investment Management AB now owns 1,084,590 shares of the company’s stock worth $507,393,000 after acquiring an additional 108,849 shares in the last quarter. Nomura Asset Management Co. Ltd. boosted its holdings in shares of HCA Healthcare by 6.2% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock worth $29,990,000 after acquiring an additional 3,724 shares in the last quarter. Hudson Bay Capital Management LP boosted its holdings in shares of HCA Healthcare by 154.5% in the 3rd quarter. Hudson Bay Capital Management LP now owns 4,693 shares of the company’s stock worth $2,000,000 after acquiring an additional 2,849 shares in the last quarter. Advisors Capital Management LLC boosted its holdings in shares of HCA Healthcare by 61.5% in the 4th quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock worth $3,192,000 after acquiring an additional 2,604 shares in the last quarter. Finally, CWA Asset Management Group LLC boosted its holdings in shares of HCA Healthcare by 1,062.4% in the 4th quarter. CWA Asset Management Group LLC now owns 9,555 shares of the company’s stock worth $4,461,000 after acquiring an additional 8,733 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

HCA has been the topic of several recent analyst reports. Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a report on Wednesday, March 4th. Sanford C. Bernstein reduced their price objective on HCA Healthcare from $503.00 to $413.00 and set a “market perform” rating on the stock in a report on Thursday, June 4th. TD Cowen reduced their price objective on HCA Healthcare from $561.00 to $500.00 and set a “buy” rating on the stock in a report on Monday, April 27th. Wall Street Zen downgraded HCA Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Finally, Jefferies Financial Group reaffirmed a “buy” rating and set a $525.00 price objective on shares of HCA Healthcare in a report on Friday, April 24th. Fifteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $506.14.

HCA Healthcare Stock Down 2.3%

HCA stock opened at $387.87 on Thursday. The business’s fifty day moving average is $424.54 and its 200-day moving average is $470.67. The company has a market cap of $86.05 billion, a P/E ratio of 13.34, a price-to-earnings-growth ratio of 1.26 and a beta of 1.12. HCA Healthcare, Inc. has a twelve month low of $330.00 and a twelve month high of $556.52.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. During the same period last year, the company earned $6.45 EPS. The business’s revenue for the quarter was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Research analysts anticipate that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be paid a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.73%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.